Trial Profile
An Open Label, Randomized, Single Dose, Two-Way Crossover Bioequivalence Study Comparing A New 10 Mg Atorvastatin Tablet To A 10 Mg Atorvastatin Commercial Tablet In Healthy Subjects.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 15 Mar 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Cardiovascular disorders; Heart failure; Hypercholesterolaemia; Hyperlipoproteinaemia type IIa; Hyperlipoproteinaemia type III; Hypertriglyceridaemia; Low HDL cholesterol
- Focus Pharmacokinetics
- Sponsors Pfizer
- 18 Jun 2009 New trial record